Editorial hapabapa/iStock via Getty Images
Novo Nordisk ( NOVO ) is asking the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be combined.
In a citizen petition posted on Regulations.gov, Novo Nordisk (NVO) noted
